Skip to main content
Top
Published in: Clinical and Experimental Nephrology 1/2017

01-02-2017 | Original Article

Reproducibility for pathological prognostic parameters of the Oxford classification of IgA nephropathy: a Japanese cohort study of the Ministry of Health, Labor and Welfare

Authors: Satoshi Hisano, Kensuke Joh, Ritsuko Katafuchi, Akira Shimizu, Noriaki Hashiguchi, Tetsuya Kawamura, Seiichi Matsuo, The IgA Nephropathy Study Group in Japan

Published in: Clinical and Experimental Nephrology | Issue 1/2017

Login to get access

Abstract

Background/aims

The Oxford classification of IgA nephropathy (IgAN) was proposed by international working group in 2009. Interobserver reproducibility of each pathological definition was already evaluated, but that of four pathological prognostic parameters score has not yet been assessed. We first assess the reproducibility of each pathological definition in Japanese patients. Our study is aimed to assess that of four pathological prognostic parameters score among the five Japanese pathologists.

Methods

The renal specimens from 411 Japanese patients, aged 3–85 years, with biopsied proven primary IgAN were collected from 50 facilities between 2006 and 2012. The reproducibility of pathological definitions was assessed by the intraclass correlation coefficient (ICC) and that of four pathological prognostic parameters score (mesangial hypercellularity (M), endocapillary hypercellularity (E), segmental glomerulosclerosis (S), and tubular atrophy/interstitial fibrosis (T)) was assessed by kappa statistics.

Results

The ICC of M, E, S, T, global sclerosis and cellular crescents and/or fibrocellular crescents were good or moderate agreement among the five pathologists and were well agreed with results of the Oxford study. Kappa statistics was moderate agreement for M and T score assessed with the semi-quantitative method by the Oxford group, but that was poor agreement for S and E score based on a simple “present” or “absent” assessment.

Conclusion

This is the first report to assess the reproducibility of pathological prognostic parameters score in the Oxford classification. Our study supports the utilization of the pathological lesions in routine diagnosis. The methodological assessment of pathological prognostic parameters score should be reconsidered.
Literature
1.
go back to reference D’Amico G. The commonest glomerulonephritis in the world: IgA nephropathy. Q J Med. 1987;64:709–27.PubMed D’Amico G. The commonest glomerulonephritis in the world: IgA nephropathy. Q J Med. 1987;64:709–27.PubMed
4.
go back to reference Haas M. Histologic subclassfication of IgA nephropathy: a clinicopathologic study of 244 cases. Am J Kidney Dis. 1997;29:829–42.CrossRefPubMed Haas M. Histologic subclassfication of IgA nephropathy: a clinicopathologic study of 244 cases. Am J Kidney Dis. 1997;29:829–42.CrossRefPubMed
5.
go back to reference Katafuchi R, Kiyoshi Y, Oh Y, et al. Glomerular score as a prognosticator in IgA nephropathy: its usefulness and limitation. Clin Nephrol. 1998;l49:1–8. Katafuchi R, Kiyoshi Y, Oh Y, et al. Glomerular score as a prognosticator in IgA nephropathy: its usefulness and limitation. Clin Nephrol. 1998;l49:1–8.
6.
go back to reference Wakai K, Kawamura T, Endoh M, et al. A scoring system to predict renal outcome in IgA nephropathy: from a nation-wide prospective study. Nephrol Dial Transplant. 2006;21:2800–8.CrossRefPubMed Wakai K, Kawamura T, Endoh M, et al. A scoring system to predict renal outcome in IgA nephropathy: from a nation-wide prospective study. Nephrol Dial Transplant. 2006;21:2800–8.CrossRefPubMed
7.
go back to reference Lee HS, Lee MS, Lee SM, et al. Histological grading of IgA nephropathy predicting renal outcome: revisting H.S. Lee’s glomerular grading system. Nephrol Dial Transplant. 2005;20:342–8.CrossRefPubMed Lee HS, Lee MS, Lee SM, et al. Histological grading of IgA nephropathy predicting renal outcome: revisting H.S. Lee’s glomerular grading system. Nephrol Dial Transplant. 2005;20:342–8.CrossRefPubMed
8.
go back to reference A working Group of the International IgA Nephropathy Network and the Renal Pathology Society, Cattran DC, Coppo R, Cook HT, et al. The Oxford classification of IgA nephropathy: rational, clinicopathological correlations, and classification. Kidney Int. 2009;76:534–45.CrossRef A working Group of the International IgA Nephropathy Network and the Renal Pathology Society, Cattran DC, Coppo R, Cook HT, et al. The Oxford classification of IgA nephropathy: rational, clinicopathological correlations, and classification. Kidney Int. 2009;76:534–45.CrossRef
9.
go back to reference A working Group of the International IgA Nephropathy Network and the Renal Pathology Society, Roberts ISD, Cook HT, Troyanov S, et al. The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility. Kidney Int. 2009;76:546–56.CrossRef A working Group of the International IgA Nephropathy Network and the Renal Pathology Society, Roberts ISD, Cook HT, Troyanov S, et al. The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility. Kidney Int. 2009;76:546–56.CrossRef
10.
go back to reference Katafuchi R, Ninomiya T, Nagata M, et al. Validation study of Oxford classification of IgA nephropathy: the significance of extracapillary proliferation. Clin J Am Soc Nephrol. 2011;6:2806–13.CrossRefPubMedPubMedCentral Katafuchi R, Ninomiya T, Nagata M, et al. Validation study of Oxford classification of IgA nephropathy: the significance of extracapillary proliferation. Clin J Am Soc Nephrol. 2011;6:2806–13.CrossRefPubMedPubMedCentral
11.
go back to reference Coppo R, Troyanov S, Camilla R, et al. The Oxford IgA nephropathy clinicopathological classification is valid for children as well as adults. Kidney Int. 2010;77:921–7.CrossRefPubMed Coppo R, Troyanov S, Camilla R, et al. The Oxford IgA nephropathy clinicopathological classification is valid for children as well as adults. Kidney Int. 2010;77:921–7.CrossRefPubMed
12.
go back to reference Herzenberg AM, Fogo AB, Reich HN, et al. Validation of the Oxford classification of IgA nephropathy. Kidney Int. 2011;80:310–7.CrossRefPubMed Herzenberg AM, Fogo AB, Reich HN, et al. Validation of the Oxford classification of IgA nephropathy. Kidney Int. 2011;80:310–7.CrossRefPubMed
13.
go back to reference Shi S-F, Wang S-X, Jiang L, et al. Pathologic predictors of renal outcome and therapeutic efficacy in IgA nephropathy: validation of the Oxford classification. Clin J Am Soc Nephrol. 2011;6:2175–84.CrossRefPubMedPubMedCentral Shi S-F, Wang S-X, Jiang L, et al. Pathologic predictors of renal outcome and therapeutic efficacy in IgA nephropathy: validation of the Oxford classification. Clin J Am Soc Nephrol. 2011;6:2175–84.CrossRefPubMedPubMedCentral
14.
15.
go back to reference Shima Y, Nakanishi K, Hama T, et al. Validity of the Oxford classification of IgA nephropathy in children. Pediatr Nephrol. 2012;27:783–92.CrossRefPubMed Shima Y, Nakanishi K, Hama T, et al. Validity of the Oxford classification of IgA nephropathy in children. Pediatr Nephrol. 2012;27:783–92.CrossRefPubMed
16.
go back to reference Lee H, Yi SH, Seo MS, et al. Validation of the Oxford classification of IgA nephropathy: a single-center study in Korean adults. Korean J Intern Med. 2012;27:293–300.CrossRefPubMedPubMedCentral Lee H, Yi SH, Seo MS, et al. Validation of the Oxford classification of IgA nephropathy: a single-center study in Korean adults. Korean J Intern Med. 2012;27:293–300.CrossRefPubMedPubMedCentral
17.
go back to reference Tanaka S, Ninomiya T, Katafuchi R, et al. Development and validation of a prediction rule using the Oxford classification in IgA nephropathy. Clin J Am Soc Nephrol. 2013;8:2082–90.CrossRefPubMedPubMedCentral Tanaka S, Ninomiya T, Katafuchi R, et al. Development and validation of a prediction rule using the Oxford classification in IgA nephropathy. Clin J Am Soc Nephrol. 2013;8:2082–90.CrossRefPubMedPubMedCentral
18.
go back to reference Landis JR, Koch GG. An appilication of hierarchial kappa-type statistics in the assessment of majority agreement among multiple observers. Biometrics. 1977;33:363–74.CrossRefPubMed Landis JR, Koch GG. An appilication of hierarchial kappa-type statistics in the assessment of majority agreement among multiple observers. Biometrics. 1977;33:363–74.CrossRefPubMed
19.
go back to reference Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159–74.CrossRefPubMed Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159–74.CrossRefPubMed
Metadata
Title
Reproducibility for pathological prognostic parameters of the Oxford classification of IgA nephropathy: a Japanese cohort study of the Ministry of Health, Labor and Welfare
Authors
Satoshi Hisano
Kensuke Joh
Ritsuko Katafuchi
Akira Shimizu
Noriaki Hashiguchi
Tetsuya Kawamura
Seiichi Matsuo
The IgA Nephropathy Study Group in Japan
Publication date
01-02-2017
Publisher
Springer Japan
Published in
Clinical and Experimental Nephrology / Issue 1/2017
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-016-1258-8

Other articles of this Issue 1/2017

Clinical and Experimental Nephrology 1/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine